DJIA 15,914.74 -99.64 -0.62%
NASDAQ 4,283.59 14.83 0.35%
S&P 500 1,851.86 -0.35 -0.02%
market minute promo

Ophthotech (NASDAQ: OPHT)

47.03 0.69 (1.49%)

Quote as of

company name or ticker

Recent Quotes

OPHT $47.03 1.49%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.94
Previous Close $46.34
Daily Range $46.42 - $50.66
52-Week Range $35.72 - $80.00
Market Cap $1.6B
P/E Ratio -19.23
Dividend (Yield) $0.00 (0.0%)
Volume 564,161
Average Daily Volume 641,432
Current FY EPS -$3.46



Ophthotech (OPHT) Description

Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye with a focus on developing therapeutics for age-related macular degeneration. Website:

News & Commentary Rss Feed

Why Ophthotech Corporation Shares Tumbled 31% in January

The launch of trials in dry age-related macular degeneration failed to spark shares last month.

Ophthotech Enters Oversold Territory (OPHT)

Insider Trading Alert - TLMR, TWC And OPHT Traded By Insiders

Regeneron Is Now A Sell For Chardan

First Week of OPHT September 16th Options Trading

Ophthotech (OPHT) Is Today's Dead Cat Bounce Stock

Why Opthotech Corporation Shares Skyrocketed by 75% in 2015

A potential to change the standard of care in a multibillion-dollar market has sparked investor enthusiasm.

Today Ophthotech (OPHT) Hits New Lifetime High

Ophthotech (OPHT) Stock: Weak On High Volume Today

3 Small-Cap Biotech Stocks With Big News Coming in 2016

Clinical trial results will be coming out next year that could significantly move the shares in these stocks higher or lower.

See More OPHT News...